-
1
Supplementary Table S3 from Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric Cancer
Foilsithe / Cruthaithe 2025Ábhair: -
2
Supplementary Table S4 from Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric Cancer
Foilsithe / Cruthaithe 2025Ábhair: -
3
Supplementary Table S2 from Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric Cancer
Foilsithe / Cruthaithe 2025Ábhair: -
4
Supplementary Table S1 from Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric Cancer
Foilsithe / Cruthaithe 2025Ábhair: -
5
Figure 1 from Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma
Foilsithe / Cruthaithe 2025Ábhair: -
6
Figure 4 from Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma
Foilsithe / Cruthaithe 2025Ábhair: -
7
Figure 2 from Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma
Foilsithe / Cruthaithe 2025Ábhair: -
8
Figure 5 from Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma
Foilsithe / Cruthaithe 2025Ábhair: -
9
Table 1 from Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma
Foilsithe / Cruthaithe 2025Ábhair: -
10
Figure 3 from Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma
Foilsithe / Cruthaithe 2025Ábhair: -
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
Figures S1-S2 from Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain Metastases
Foilsithe / Cruthaithe 2025Ábhair: